<DOC>
	<DOCNO>NCT00002110</DOCNO>
	<brief_summary>To determine safety tolerance low-dose versus high-dose cysteamine administer concurrently zidovudine ( AZT ) . To determine pharmacokinetics effect immune function viral load patient receive drug regimen .</brief_summary>
	<brief_title>A Phase II/III Study Cysteamine ( Mercaptoethylamine ) Zidovudine Treatment HIV Disease</brief_title>
	<detailed_description>Patients receive high low dos cysteamine plus AZT placebo plus AZT . The target dose cysteamine determine titration dose 6-week period , patient receive 24 additional week treatment . An initial cohort 36 patient enrol 10-week pilot phase . Accrual temporarily suspend data pilot phase assess .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<mesh_term>Zidovudine</mesh_term>
	<mesh_term>Cysteamine</mesh_term>
	<criteria>Inclusion Criteria Concurrent Medication : Allowed : Chemoprophylaxis Pneumocystis carinii pneumonia , candidiasis , Mycobacterium tuberculosis , herpes prescribed investigator . Recombinant erythropoietin GCSF clinically indicate . Patients must : Documented HIV infection . CD4 count 300 500 cells/mm3 . Prior AZT therapy least 3 month le 12 month prior study entry . No past current AIDSdefining opportunistic infection . Exclusion Criteria Coexisting Condition : Patients follow symptoms condition exclude : Kaposi 's sarcoma require systemic therapy . Active malignancy basal cell carcinoma situ cervical carcinoma . Concurrent Medication : Excluded : Antiretroviral therapy AZT . Immunosuppressive drug . Investigational HIV drugs/therapies study drug . Interferon . Steroids . Hematopoietins . Cytotoxic chemotherapy include Adriamycin , bleomycin , vincristine . Concurrent Treatment : Excluded : Radiation therapy . Patients follow prior condition exclude : History treatmentlimiting intolerance 500600 mg AZT daily manifest recurrent grade 3 toxicity prior grade 4 toxicity . Prior Medication : Excluded : Prior antiretroviral therapy AZT . Required : AZT least 3 month 12 month prior study entry .</criteria>
	<gender>All</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 1995</verification_date>
	<keyword>Drug Therapy , Combination</keyword>
	<keyword>AIDS-Related Complex</keyword>
	<keyword>Zidovudine</keyword>
	<keyword>Cysteamine</keyword>
</DOC>